AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9364693 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive-active hepatitis B immunization
Number of subjects: 705
Study 9364693 — intervention group
Group type: EXPERIMENTAL
Intervention: Starting active immunization at birth
Number of subjects: 705
Study 9364693 — intervention group
Group type: EXPERIMENTAL
Intervention: Starting active immunization at 3 months of age
Number of subjects: 705
Study 9364693 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal HBV DNA < 150 pg ml-1
Number of subjects: 705
Study 9364693 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal HBV DNA > 150 pg ml-1
Number of subjects: 705
Study 9364693 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant DKTP vaccination
Number of subjects: 705
Study 1551035 — intervention group
Group type: EXPERIMENTAL
Intervention: terfenadine 120 mg twice daily
Number of subjects: 52
Study 1551035 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 52
Study 3861070 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra early physical contact (EC)
Number of subjects: 78
Study 3861070 — intervention group
Group type: COMPARATOR
Intervention: Regular contact (RC)
Number of subjects: 78
Study 29580640 — intervention group
Group type: EXPERIMENTAL
Intervention: EasySix™ vaccine
Number of subjects: 284
Study 29580640 — intervention group
Group type: COMPARATOR
Intervention: Pentavac SD® (DTwP‐HepB/Hib) and Imovax Polio®
Number of subjects: 284
Study 27559737 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline injection (pain)
Number of subjects: 22
Study 27559737 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline injection (control)
Number of subjects: 22
Study 24688081 — intervention group
Group type: EXPERIMENTAL
Intervention: Benefit-finding intervention
Number of subjects: 25
Study 24688081 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 25
Study 22828857 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose remifentanil (0.05-0.125 μg/kg/min) and propofol (1-3 mg/kg/h)
Number of subjects: 12
Study 22828857 — intervention group
Group type: COMPARATOR
Intervention: Propofol (1-3 mg/kg/h)
Number of subjects: 12
Study 20653166 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese medicine (dissolving phlegm-stasis)
Number of subjects: 100
Study 20653166 — intervention group
Group type: COMPARATOR
Intervention: Votalin and Vitamin C (control)
Number of subjects: 100
Study 17923653 — intervention group
Group type: EXPERIMENTAL
Intervention: Health report card with counselling on smoking, exercise, nutrition and stress (intervention group)
Number of subjects: 310
Study 17923653 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 310
Study 17923653 — intervention group
Group type: EXPERIMENTAL
Intervention: Health report card with counselling (intervention group)
Number of subjects: 310
Study 16275486 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaxolol hydrochloride (5 mg daily for 3 weeks)
Number of subjects: 17
Study 12175392 — intervention group
Group type: EXPERIMENTAL
Intervention: tolterodine 2 mg twice daily for 10 weeks
Number of subjects: 106
Study 12175392 — intervention group
Group type: COMPARATOR
Intervention: oxybutynin 5 mg twice daily for 10 weeks
Number of subjects: 106
Study 10442207 — intervention group
Group type: EXPERIMENTAL
Intervention: sustained release capsules containing 100 mg tramadol hydrochloride, total of 6 capsules at intervals of 12 h
Number of subjects: 24
Study 10442207 — intervention group
Group type: COMPARATOR
Intervention: instant release capsules containing 50 mg tramadol hydrochloride, total of 12 capsules at intervals of 6 h
Number of subjects: 24
Study 7598920 — intervention group
Group type: EXPERIMENTAL
Intervention: eltanolone 0.58 mg/kg
Number of subjects: 40
Study 7598920 — intervention group
Group type: COMPARATOR
Intervention: propofol 1.7 mg/kg
Number of subjects: 40
Study 2145877 — intervention group
Group type: EXPERIMENTAL
Intervention: Back school plus wearing a custom molded lumbosacral orthosis
Number of subjects: 90
Study 2145877 — intervention group
Group type: COMPARATOR
Intervention: Back school only
Number of subjects: 90
Study 2145877 — intervention group
Group type: COMPARATOR
Intervention: True controls, no back school, no brace orthoses
Number of subjects: 90
Study 2145877 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthoses and training-group
Number of subjects: 90
Study 876810 — intervention group
Group type: EXPERIMENTAL
Intervention: Dark-adapted condition
Number of subjects: 33
Study 876810 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate-adapted condition
Number of subjects: 33
Study 876810 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-adapted condition
Number of subjects: 33
Study 31129929 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote patient management (RPM)
Number of subjects: 1538
Study 31129929 — intervention group
Group type: COMPARATOR
Intervention: Not recommended for RPM (control group)
Number of subjects: 1538
Study 29373884 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone suppositories (400 mg per night) until delivery or completion of the 34th gestational week
Number of subjects: 120
Study 29373884 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 26480548 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture therapy at Shenmen (HT 7), Baihui (GV 20), Yintang (GV 29), Hegu (LI 4), Taichong (LR 3), needles retained for 20 min, treatment once a day for 2 weeks (1 session).
Number of subjects: 70
Study 26480548 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of trazodone, 100 mg, once a day for 2 weeks (1 session).
Number of subjects: 70
Study 23567596 — intervention group
Group type: EXPERIMENTAL
Intervention: P. ginseng (100 mg/d)
Number of subjects: 38
Study 23567596 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (25 mg/d)
Number of subjects: 38
Study 21766893 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with a greater chance of success
Number of subjects: 58
Study 21766893 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with lower cost
Number of subjects: 58
Study 21766893 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with shorter duration before being able to exercise free of pain
Number of subjects: 58
Study 21766893 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with lower chance of side effects
Number of subjects: 58
Study 21766893 — intervention group
Group type: EXPERIMENTAL
Intervention: Injections as a stand-alone treatment
Number of subjects: 58
Study 21766893 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% increase in chance of treatment success
Number of subjects: 58
Study 21766893 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercises
Number of subjects: 58
Study 19106150 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective laser trabeculoplasty (SLT)
Number of subjects: 40
Study 19106150 — intervention group
Group type: COMPARATOR
Intervention: Latanoprost
Number of subjects: 40
Study 16900564 — intervention group
Group type: EXPERIMENTAL
Intervention: Autoregressive linear mixed effects model
Number of subjects: 0
Study 16900564 — intervention group
Group type: EXPERIMENTAL
Intervention: Error structures proposed
Number of subjects: 0
Study 15090391 — intervention group
Group type: EXPERIMENTAL
Intervention: Screw-in anchors (vertical sutures)
Number of subjects: 21
Study 15090391 — intervention group
Group type: EXPERIMENTAL
Intervention: Screw-in anchors (horizontal sutures)
Number of subjects: 21
Study 15090391 — intervention group
Group type: COMPARATOR
Intervention: Bioabsorbable tacks
Number of subjects: 21
Study 11574347 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.025, 0.05, and 0.1 mg/kg)
Number of subjects: 34
Study 11574347 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (0.25, 0.5, and 1.0 mg/kg)
Number of subjects: 34
Study 11574347 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy patients)
Number of subjects: 34
Study 9693434 — intervention group
Group type: EXPERIMENTAL
Intervention: NPPV (Noninvasive Positive Pressure Ventilation)
Number of subjects: 58
Study 9693434 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (non-NPPV)
Number of subjects: 58
Study 8159123 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth centre care (EG)
Number of subjects: 1230
Study 8159123 — intervention group
Group type: COMPARATOR
Intervention: Standard obstetric care (CG)
Number of subjects: 1230
Study 2900901 — intervention group
Group type: EXPERIMENTAL
Intervention: FAT (5-fluorouracil, doxorubicin, triazinate)
Number of subjects: 100
Study 2900901 — intervention group
Group type: EXPERIMENTAL
Intervention: FAP (5-fluorouracil, doxorubicin, cisplatin)
Number of subjects: 100
Study 2900901 — intervention group
Group type: COMPARATOR
Intervention: FAMe (5-fluorouracil, doxorubicin, semustine)
Number of subjects: 100
Study 31932932 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative laparoscopic-guided TAP block (TAP-lap)
Number of subjects: 140
Study 31932932 — intervention group
Group type: COMPARATOR
Intervention: Control (no TAP block)
Number of subjects: 140
Study 29688873 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behavioural Therapy (DBT) for 12 weeks
Number of subjects: 48
Study 29688873 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 48
Study 27334418 — intervention group
Group type: EXPERIMENTAL
Intervention: Wireless self-monitoring program (n=52)
Number of subjects: 95
Study 27334418 — intervention group
Group type: COMPARATOR
Intervention: Standard disease management program (n=43)
Number of subjects: 95
Study 24061274 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent seasonal influenza vaccine (TIV)
Number of subjects: 0
Study 24061274 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23663510 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential bilateral rTMS
Number of subjects: 179
Study 23663510 — intervention group
Group type: COMPARATOR
Intervention: Right-sided unilateral rTMS
Number of subjects: 179
Study 20180109 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl (2 microg/kg)
Number of subjects: 0
Study 20180109 — intervention group
Group type: COMPARATOR
Intervention: Sterile water (placebo)
Number of subjects: 0
Study 18575851 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg orally
Number of subjects: 0
Study 18575851 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15793053 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic Harmonic Scalpel
Number of subjects: 100
Study 15793053 — intervention group
Group type: COMPARATOR
Intervention: Standard method (hemostatic clips, scissors, minimal electrocautery)
Number of subjects: 100
Study 12218529 — intervention group
Group type: EXPERIMENTAL
Intervention: Mivacurium infusion (0.2 mg/kg bolus followed by 3, 5, or 7 microg/kg/min infusion)
Number of subjects: 8
Study 10333832 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic pressure (50 mm Hg)
Number of subjects: 15
Study 10333832 — intervention group
Group type: COMPARATOR
Intervention: Placebo pressure (15 mm Hg)
Number of subjects: 15
Study 8599955 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc-exametazime labelled leucocytes
Number of subjects: 23
Study 8599955 — intervention group
Group type: COMPARATOR
Intervention: 99mTc-labelled antibodies against granulocyte non-specific cross-reacting antigen-95
Number of subjects: 23
Study 1924659 — intervention group
Group type: EXPERIMENTAL
Intervention: mianserin (30 mg to 150 mg)
Number of subjects: 150
Study 1924659 — intervention group
Group type: EXPERIMENTAL
Intervention: amitriptyline (60 mg to 300 mg)
Number of subjects: 150
Study 1924659 — intervention group
Group type: COMPARATOR
Intervention: placebo (1 to 5 capsules at bedtime)
Number of subjects: 150
Study 7051248 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral trimethoprim‐sulfamethoxazole and carbenicillin (TMP‐SMZ‐C)
Number of subjects: 0
Study 7051248 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin and carbenicillin (G‐C)
Number of subjects: 0
Study 31531150 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG elimination diet
Number of subjects: 60
Study 31531150 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 60
Study 31531150 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet combined with probiotics
Number of subjects: 60
Study 31531150 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 60
Study 29398152 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily online CBCT IGRT (7 mm margins to PTV)
Number of subjects: 257
Study 29398152 — intervention group
Group type: COMPARATOR
Intervention: Weekly offline portal imaging (15 mm margins to PTV)
Number of subjects: 257
Study 26636178 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 93
Study 26636178 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 24170679 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong
Number of subjects: 40
Study 24170679 — intervention group
Group type: COMPARATOR
Intervention: Stretching
Number of subjects: 40
Study 22485048 — intervention group
Group type: EXPERIMENTAL
Intervention: ACWY-TT alone
Number of subjects: 0
Study 22485048 — intervention group
Group type: EXPERIMENTAL
Intervention: Coad (ACWY-TT with seasonal influenza vaccine)
Number of subjects: 0
Study 22485048 — intervention group
Group type: COMPARATOR
Intervention: MenPS alone
Number of subjects: 0
Study 22485048 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study 20331579 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 apheresis treatments
Number of subjects: 196
Study 20331579 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 apheresis treatments
Number of subjects: 196
Study 17363187 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast radiotherapy + boost (n = 414)
Number of subjects: 869
Study 17363187 — intervention group
Group type: COMPARATOR
Intervention: No breast radiotherapy (n = 417)
Number of subjects: 869
Study 17043073 — intervention group
Group type: EXPERIMENTAL
Intervention: LV-Epi pacing
Number of subjects: 36
Study 17043073 — intervention group
Group type: EXPERIMENTAL
Intervention: Bi-V pacing
Number of subjects: 36
Study 17043073 — intervention group
Group type: COMPARATOR
Intervention: RV-Endo pacing
Number of subjects: 36
Study 17043073 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up observations
Number of subjects: 36
Study 12900242 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser treatment for 3+ cataracts
Number of subjects: 147
Study 12900242 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser treatment for 4+ cataracts
Number of subjects: 147
Study 12900242 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound treatment for all cataract densities
Number of subjects: 147
Study 10919019 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser combined with percutaneous radiotherapy (group 1)
Number of subjects: 39
Study 10919019 — intervention group
Group type: COMPARATOR
Intervention: Self-expanding metal stent (group 2)
Number of subjects: 39
Study 10919019 — intervention group
Group type: COMPARATOR
Intervention: Self-expanding metal stent with initial laser therapy (group 2a)
Number of subjects: 39
Study 8731468 — intervention group
Group type: EXPERIMENTAL
Intervention: Piagetian principles training
Number of subjects: 25
Study 8731468 — intervention group
Group type: COMPARATOR
Intervention: Common population pool
Number of subjects: 25
Study 1358674 — intervention group
Group type: EXPERIMENTAL
Intervention: Turbohaler (T)
Number of subjects: 36
Study 1358674 — intervention group
Group type: COMPARATOR
Intervention: Diskhaler (D)
Number of subjects: 36
Study 1358674 — intervention group
Group type: EXPERIMENTAL
Intervention: Both inhalers
Number of subjects: 36
Study 6143970 — intervention group
Group type: EXPERIMENTAL
Intervention: Active pulsed magnetic field stimulators
Number of subjects: 16
Study 6143970 — intervention group
Group type: COMPARATOR
Intervention: Dummy pulsed magnetic field stimulators (Control)
Number of subjects: 16
Study 30621948 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with HFrEF
Number of subjects: 13500
Study 30621948 — intervention group
Group type: COMPARATOR
Intervention: Device therapy in women
Number of subjects: 13500
Study 29526837 — intervention group
Group type: EXPERIMENTAL
Intervention: Core and mobility training (EG; n=8) - 2 weekly sessions of 50 minutes for 10 weeks
Number of subjects: 24
Study 29526837 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG; n=16) - received ergonomic guidelines but no core and mobility training
Number of subjects: 24
Study 29526837 — intervention group
Group type: COMPARATOR
Intervention: Comparison between EG and CG post-intervention
Number of subjects: 24
Study 26681684 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent radiotherapy with letrozole (arm A)
Number of subjects: 150
Study 26681684 — intervention group
Group type: COMPARATOR
Intervention: Sequential radiotherapy with letrozole (arm B)
Number of subjects: 150
Study 26681684 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms (A and B)
Number of subjects: 150
Study 26681684 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with grade ≥2 RISF
Number of subjects: 150
Study 26681684 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with identified SNPs
Number of subjects: 150
Study 25194287 — intervention group
Group type: EXPERIMENTAL
Intervention: Strategy of adjusting therapy to achieve and maintain a target NT-proBNP level of <1,000 pg/ml
Number of subjects: 1100
Study 25194287 — intervention group
Group type: COMPARATOR
Intervention: Usual care (optimized guideline-recommended therapy)
Number of subjects: 1100
Study 22762346 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEP-heparin plaster
Number of subjects: 331
Study 22762346 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEP plaster
Number of subjects: 331
Study 22762346 — intervention group
Group type: COMPARATOR
Intervention: Placebo plaster
Number of subjects: 331
Study 20573405 — intervention group
Group type: EXPERIMENTAL
Intervention: 375µg interferon (IFN)‐β‐1b
Number of subjects: 37
Study 20573405 — intervention group
Group type: EXPERIMENTAL
Intervention: 250µg interferon (IFN)‐β‐1b
Number of subjects: 37
Study 20573405 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 37
Study 17659926 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 191
Study 17659926 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg
Number of subjects: 191
Study 17659926 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg
Number of subjects: 191
Study 17659926 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 191
Study 16282294 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosquito nets treated with lambda-cyhalothrin
Number of subjects: 432
Study 12022323 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 51
Study 12022323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 10362152 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate, 50 mg/m2
Number of subjects: 27
Study 10362152 — intervention group
Group type: COMPARATOR
Intervention: 6‐mercaptopurine, 200 mg
Number of subjects: 27
Study 10362152 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 27
Study 7739158 — intervention group
Group type: EXPERIMENTAL
Intervention: 123I-BMIPP imaging
Number of subjects: 25
Study 1838561 — intervention group
Group type: EXPERIMENTAL
Intervention: GULin vocoder
Number of subjects: 13
Study 1838561 — intervention group
Group type: COMPARATOR
Intervention: CIDLog vocoder
Number of subjects: 13
Study 1838561 — intervention group
Group type: EXPERIMENTAL
Intervention: CIDLin vocoder
Number of subjects: 13
Study 1838561 — intervention group
Group type: COMPARATOR
Intervention: Visual-only control
Number of subjects: 13
Study 1838561 — intervention group
Group type: COMPARATOR
Intervention: Vocoder control
Number of subjects: 13
Study 6804241 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 59
Study 6804241 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 59
Study 6804241 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 30882641 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal intervention involving nurses (reinforcing knowledge on antibiotics and UTI, decision aid diagram, communication skills improvement, increased involvement in prescription process).
Number of subjects: 40
Study 30882641 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care without the multimodal intervention).
Number of subjects: 40
Study 27558855 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuff position at the most distal location
Number of subjects: 20
Study 27558855 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuff position at the distal part
Number of subjects: 20
Study 27558855 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal lower leg
Number of subjects: 20
Study 27558855 — intervention group
Group type: EXPERIMENTAL
Intervention: Staircase pattern
Number of subjects: 20
Study 26921746 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (12.5 mg twice per day for the 1st week, 25 mg twice per day during the 2nd week, and 75 mg/d from the 3rd week to the end of the 16th week)
Number of subjects: 73
Study 26921746 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 73
Study 25073453 — intervention group
Group type: EXPERIMENTAL
Intervention: SINGLE training condition
Number of subjects: 42
Study 25073453 — intervention group
Group type: EXPERIMENTAL
Intervention: FIXED training condition
Number of subjects: 42
Study 25073453 — intervention group
Group type: EXPERIMENTAL
Intervention: VARIABLE training condition
Number of subjects: 42
Study 23074234 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive i.v. insulin therapy (BG = 70-110 mg/dl)
Number of subjects: 93
Study 23074234 — intervention group
Group type: COMPARATOR
Intervention: Standard s.c. insulin therapy (BG = 70-180 mg/dl)
Number of subjects: 93
Study 23074234 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive i.v. insulin therapy
Number of subjects: 93
Study 23074234 — intervention group
Group type: COMPARATOR
Intervention: Standard s.c. insulin therapy
Number of subjects: 93
Study 18678766 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane (n=77)
Number of subjects: 142